scispace - formally typeset
T

Tilman B. Drüeke

Researcher at French Institute of Health and Medical Research

Publications -  415
Citations -  22817

Tilman B. Drüeke is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Kidney disease & Hyperparathyroidism. The author has an hindex of 68, co-authored 413 publications receiving 21471 citations. Previous affiliations of Tilman B. Drüeke include Versailles Saint-Quentin-en-Yvelines University & University of Paris-Sud.

Papers
More filters
Journal ArticleDOI

Urolithiasis in patients with end stage renal failure

TL;DR: This study indicates that a significant proportion of stones formed by hemodialysis patients may be due to metabolic and iatrogenic factors and suggests that accurate analysis of such stones provides useful information on pathogenetic factors and consequently may give clues to their prophylaxis.
Journal ArticleDOI

Value of the 99mTc-methylene diphosphonate bone scan in renal osteodystrophy.

TL;DR: In hemodialysis patients with symptomatic bone disease, the 99mTc-MDP bone scan provides useful information for the differential diagnosis between dialysis-related osteomalacia and secondary hyperparathyroidism.
Journal ArticleDOI

Reoperation for secondary hyperparathyroidism in hemodialysis patients.

TL;DR: 25 reoperations done in 21 patients who are part of a series of 248 patients operated on for secondary hyperparathyroidism shows the difficulties of localizing unique or multiple sites of parathyroid hormone overproduction despite the availability of many diagnostic approaches.
Journal ArticleDOI

Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients

TL;DR: Recent preliminary findings in uremic patients provide support for some aspects of the suggestion that moderate hyperhomocyst(e)inemia may predispose to endothelium dysfunction through a mechanism that involves generation of reactive oxygen species and a decrease in nitric oxide bioavailability.
Journal ArticleDOI

Advanced oxidation protein products, parathyroid hormone and vascular calcification in uremia.

TL;DR: Patients with chronic renal failure have other risk factors such as oxidative stress, inflammation, hyperparathyroidism, hypoparathyroidistan, hypercalcemia, hyperphosphatemia, and overtreatment with calcium and vitamin D, which may have a better predictive value than classical risk factors for coronary heart disease in uremic patients.